362 related articles for article (PubMed ID: 11572317)
1. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
Whitacre DC; Karnas KJ; Miesfeld RL
Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
[TBL] [Abstract][Full Text] [Related]
2. Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation.
Rundlett SE; Miesfeld RL
Mol Cell Endocrinol; 1995 Mar; 109(1):1-10. PubMed ID: 7789609
[TBL] [Abstract][Full Text] [Related]
3. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
[TBL] [Abstract][Full Text] [Related]
4. Nuclear extracts enhance the interaction of fusion proteins containing the DNA-binding domain of the androgen and glucocorticoid receptor with androgen and glucocorticoid response elements.
De Vos P; Claessens F; Celis L; Peeters B; Rombauts W; Heyns W; Verhoeven G
J Steroid Biochem Mol Biol; 1994 Mar; 48(4):317-23. PubMed ID: 8142310
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells.
Chapman MS; Askew DJ; Kuscuoglu U; Miesfeld RL
Mol Endocrinol; 1996 Aug; 10(8):967-78. PubMed ID: 8843413
[TBL] [Abstract][Full Text] [Related]
6. Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation.
Scheller A; Hughes E; Golden KL; Robins DM
J Biol Chem; 1998 Sep; 273(37):24216-22. PubMed ID: 9727045
[TBL] [Abstract][Full Text] [Related]
7. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
[TBL] [Abstract][Full Text] [Related]
8. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
Zhang S; Liang X; Danielsen M
Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
[TBL] [Abstract][Full Text] [Related]
9. A cell-specific and selective effect on transactivation by the androgen receptor.
Gordon DA; Chamberlain NL; Flomerfelt FA; Miesfeld RL
Exp Cell Res; 1995 Apr; 217(2):368-77. PubMed ID: 7698238
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer.
Grad JM; Lyons LS; Robins DM; Burnstein KL
Endocrinology; 2001 Mar; 142(3):1107-16. PubMed ID: 11181525
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.
Verrijdt G; Haelens A; Schoenmakers E; Rombauts W; Claessens F
Biochem J; 2002 Jan; 361(Pt 1):97-103. PubMed ID: 11742533
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.
Rennie PS; Bruchovsky N; Leco KJ; Sheppard PC; McQueen SA; Cheng H; Snoek R; Hamel A; Bock ME; MacDonald BS
Mol Endocrinol; 1993 Jan; 7(1):23-36. PubMed ID: 8446105
[TBL] [Abstract][Full Text] [Related]
14. Interaction of androgen and glucocorticoid receptor DNA-binding domains with their response elements.
De Vos P; Claessens F; Peeters B; Rombauts W; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1993 Jan; 90(2):R11-6. PubMed ID: 8388338
[TBL] [Abstract][Full Text] [Related]
15. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
16. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
Boruk M; Savory JG; Haché RJ
Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
[TBL] [Abstract][Full Text] [Related]
17. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
18. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
Govindan MV
Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
[TBL] [Abstract][Full Text] [Related]
19. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation.
Rundlett SE; Wu XP; Miesfeld RL
Mol Endocrinol; 1990 May; 4(5):708-14. PubMed ID: 2274054
[TBL] [Abstract][Full Text] [Related]
20. Differential transactivation by the androgen receptor in prostate cancer cells.
Snoek R; Bruchovsky N; Kasper S; Matusik RJ; Gleave M; Sato N; Mawji NR; Rennie PS
Prostate; 1998 Sep; 36(4):256-63. PubMed ID: 9719026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
